318 related articles for article (PubMed ID: 23739078)
1. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
2. Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P; Cornaglia G
Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
[No Abstract] [Full Text] [Related]
3. Colonization of high-risk children with carbapenemase-producing Enterobacteriaceae in Greece.
Mougkou K; Michos A; Spyridopoulou K; Daikos GL; Spyridis N; Syriopoulou V; Zaoutis T
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):757-9. PubMed ID: 23739084
[No Abstract] [Full Text] [Related]
4. Carbapenemase-producing enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey.
Colombo S; Scolfaro C; Calitri C; Denina M; Carraro F; De Intinis G; Tovo PA
Infect Control Hosp Epidemiol; 2014 May; 35(5):599-601. PubMed ID: 24709738
[No Abstract] [Full Text] [Related]
5. [Laboratory detection of carbapenemase-producing Enterobacteriaceae].
Cercenado E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():8-11. PubMed ID: 26365726
[TBL] [Abstract][Full Text] [Related]
6. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
7. Infection control implications of heterogeneous resistance mechanisms in carbapenem-resistant Enterobacteriaceae (CRE).
Goodman KE; Simner PJ; Tamma PD; Milstone AM
Expert Rev Anti Infect Ther; 2016; 14(1):95-108. PubMed ID: 26535959
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
Logan LK
Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
[TBL] [Abstract][Full Text] [Related]
9. Infections caused by carbapenemase-producing Enterobacteriaceae: risk factors, clinical features and prognosis.
Paño Pardo JR; Serrano Villar S; Ramos Ramos JC; Pintado V
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():41-8. PubMed ID: 25542051
[TBL] [Abstract][Full Text] [Related]
10. NDM-1, OXA-48 and OXA-181 carbapenemase-producing Enterobacteriaceae in Sultanate of Oman.
Dortet L; Poirel L; Al Yaqoubi F; Nordmann P
Clin Microbiol Infect; 2012 May; 18(5):E144-8. PubMed ID: 22404169
[TBL] [Abstract][Full Text] [Related]
11. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
[TBL] [Abstract][Full Text] [Related]
12. Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae.
Pilmis B; Parize P; Zahar JR; Lortholary O
Eur J Clin Microbiol Infect Dis; 2014 Aug; 33(8):1263-5. PubMed ID: 24691683
[No Abstract] [Full Text] [Related]
13. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
14. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe.
Cantón R; Akóva M; Carmeli Y; Giske CG; Glupczynski Y; Gniadkowski M; Livermore DM; Miriagou V; Naas T; Rossolini GM; Samuelsen Ø; Seifert H; Woodford N; Nordmann P;
Clin Microbiol Infect; 2012 May; 18(5):413-31. PubMed ID: 22507109
[TBL] [Abstract][Full Text] [Related]
15. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and prevention of carbapenem-resistant Enterobacteriaceae in the United States.
Guh AY; Limbago BM; Kallen AJ
Expert Rev Anti Infect Ther; 2014 May; 12(5):565-80. PubMed ID: 24666262
[TBL] [Abstract][Full Text] [Related]
17. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
[TBL] [Abstract][Full Text] [Related]
18. Extended-spectrum beta-lactamase-producing organisms.
Falagas ME; Karageorgopoulos DE
J Hosp Infect; 2009 Dec; 73(4):345-54. PubMed ID: 19596491
[TBL] [Abstract][Full Text] [Related]
19. Should screening programs for carbapenemase-producing strains be implemented in ICU patients?
Oteo J
Enferm Infecc Microbiol Clin; 2017; 35(6):331-332. PubMed ID: 28104307
[No Abstract] [Full Text] [Related]
20. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]